No results for "Category:Monoamine oxidase inhibitors" (auto) in titles.

Suggestions for article titles:

1. Monoamine oxidase inhibitor: Monoamine oxidase inhibitors (MAOIs) are a class of drugs that inhibit the activity of one or both monoamine oxidase enzymes: monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B). They are best known as effective antidepressants, especially for ... (Type of medication) [100%] 2023-06-09 [Antidepressants] [Monoamine oxidase inhibitors]...
2. Monoamine oxidase inhibitor: Editor-In-Chief: C. Michael Gibson, M.S., M.D. [100%] 2023-08-08 [Antidepressants] [Monoamine oxidase inhibitors]...
3. Monoamine oxidase inhibitor: Monoamine oxidase inhibitors (MAOIs) were the first class of antidepressant medications developed. MAOIs increase levels of monoamine neurotransmitters in the synapses between neurons by deactivating one or more subtypes of the enzyme monoamine oxidase. [100%] 2023-05-17
4. Monoamine oxidase inhibitor: Monoamine oxidase inhibitors (MAOIs) are a class of drugs that inhibit the activity of one or both monoamine oxidase enzymes: monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B). They are best known as effective antidepressants, especially for ... (Type of medication) [100%] 2024-11-14 [Antidepressants] [Monoamine oxidase inhibitors]...
5. Inheritors (play): Inheritors is a four-act play written by the American dramatist Susan Glaspell, first performed in 1921 (103 years ago) (1921). The play concerns the legacy of an idealistic farmer who wills his highly coveted midwest farmland to the establishment ... (Play) [74%] 2024-01-01 [1921 plays] [Plays by Susan Glaspell]...
6. Inhibidores de la monoamino oxidasa: Los inhibidores de la monoamino oxidasa (IMAO) constituyen la categoría terapéutica a la que pertenece cierto grupo de fármacos antidepresivos y que actúan bloqueando la acción de la enzima monoamino oxidasa. Fueron los primeros antidepresivos existentes en el mercado. [67%] 2023-08-22
7. PCSK9 inhibitors: PCSK9 inhibitors are a class of medications used to treat hypercholesterolemia. In those on high doses of statins, they decrease risk of further problems by 1.5% over 2.5 years. [66%] 2024-01-01
8. PERK inhibitors: A PERK inhibitor is a small molecule compound that unlike any existing drug inhibits the expression of protein kinase RNA–like endoplasmic reticulum kinase. The (first such) inhibitor demonstrated the ability to halt brain cell death in mice with prion ... (Chemistry) [66%] 2023-12-17 [Protein kinase inhibitors]
9. PERK inhibitors: A PERK inhibitor is a small molecule compound that unlike any existing drug inhibits the expression of protein kinase RNA–like endoplasmic reticulum kinase. The (first such) inhibitor demonstrated the ability to halt brain cell death in mice with prion ... [66%] 2024-02-11 [Protein kinase inhibitors]
10. Lipase inhibitors: Lipase inhibitors are substances used to reduce the activity of lipases found in the intestine. Lipases are secreted by the pancreas when fat is present. [66%] 2023-12-19 [Lipase inhibitors] [Obesity]...
11. Protease inhibitors: Protease inhibitors (PIs) are a class of medication used to treat or prevent infection by viruses, including HIV and Hepatitis C. PIs prevent viral replication by inhibiting the activity of HIV-1 protease, an enzyme used by the viruses to ... [66%] 2023-10-09 [Antivirals] [Antiretroviral drugs]...
12. Phosphodiesterase inhibitors: Articles Most recent articles on Phosphodiesterase inhibitors Most cited articles on Phosphodiesterase inhibitors Review articles on Phosphodiesterase inhibitors Articles on Phosphodiesterase inhibitors in N Eng J Med, Lancet, BMJ Media Powerpoint slides on Phosphodiesterase inhibitors Images of Phosphodiesterase inhibitors Photos ... [66%] 2023-12-20 [Phosphodiesterase inhibitors] [Drugs]...
13. STAT inhibitors: STAT inhibitors are drugs which target signal transducer and activator of transcription (STAT) proteins, a family of cytoplasmic induction factors. Inhibitors of STAT proteins are being developed for use in cancer therapy. (Chemistry) [66%] 2023-12-15 [Enzyme inhibitors]
14. Angiokinase inhibitors: Angiokinase inhibitors are a new therapeutic target for the management of cancer. They inhibit tumour angiogenesis, one of the key processes leading to invasion and metastasis of solid tumours, by targeting receptor tyrosine kinases. (Chemistry) [66%] 2023-12-16 [Tyrosine kinase inhibitors]
15. Angiokinase inhibitors: Angiokinase inhibitors are a new therapeutic target for the management of cancer. They inhibit tumour angiogenesis, one of the key processes leading to invasion and metastasis of solid tumours, by targeting receptor tyrosine kinases. [66%] 2023-12-20 [Tyrosine kinase inhibitors]
16. STAT inhibitors: STAT inhibitors are drugs which target signal transducer and activator of transcription (STAT) proteins, a family of cytoplasmic induction factors. Inhibitors of STAT proteins are being developed for use in cancer therapy. (Drug class) [66%] 2024-09-01 [Enzyme inhibitors]
17. Oxydose: Oxydose® ÃHX'-ē-dōsè (proper noun) 1. Oxydose® is a liquid opioid narcotic elixir. [64%] 2023-03-07 [Opioids] [Drugs]...
18. Glycine oxidase: Glycine oxidase (EC 1.4.3.19) is an enzyme with systematic name glycine:oxygen oxidoreductase (deaminating). This enzyme catalyses the following chemical reaction This flavoenzyme containing non-covalently bound FAD. (Class of enzymes) [63%] 2023-03-03 [EC 1.4.3]
19. NADPH oxidase: NADPH oxidase (nicotinamide adenine dinucleotide phosphate oxidase) is a membrane-bound enzyme complex that faces the extracellular space. It can be found in the plasma membrane as well as in the membranes of phagosomes used by neutrophil white blood cells ... (Biology) [63%] 2022-11-19 [Peripheral membrane proteins]
20. Gulonolactone oxidase: Gulonolactone oxidase is an enzyme that catalyzes the reactions needed to produce ascorbic acid (vitamin C). This gene is present in most animals however it has been inactivated due to mutation in some. [63%] 2023-02-16 [Genetics]